154 related articles for article (PubMed ID: 7579396)
1. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
Marquette KA; Pittman DD; Kaufman RJ
Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
[TBL] [Abstract][Full Text] [Related]
2. Role of the B domain for factor VIII and factor V expression and function.
Pittman DD; Marquette KA; Kaufman RJ
Blood; 1994 Dec; 84(12):4214-25. PubMed ID: 7994036
[TBL] [Abstract][Full Text] [Related]
3. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms that regulate the anticoagulant function of coagulation factor V.
Thorelli E
Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.
Newell JL; Fay PJ
J Biol Chem; 2007 Aug; 282(35):25367-75. PubMed ID: 17595160
[TBL] [Abstract][Full Text] [Related]
6. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
Thorelli E; Kaufman RJ; Dahlbäck B
J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
[TBL] [Abstract][Full Text] [Related]
7. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
Villoutreix BO; Dahlbäck B
Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
[TBL] [Abstract][Full Text] [Related]
9. Exosite-interactive regions in the A1 and A2 domains of factor VIII facilitate thrombin-catalyzed cleavage of heavy chain.
Nogami K; Zhou Q; Myles T; Leung LL; Wakabayashi H; Fay PJ
J Biol Chem; 2005 May; 280(18):18476-87. PubMed ID: 15746105
[TBL] [Abstract][Full Text] [Related]
10. The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII.
Bukys MA; Orban T; Kim PY; Beck DO; Nesheim ME; Kalafatis M
J Biol Chem; 2006 Jul; 281(27):18569-80. PubMed ID: 16624813
[TBL] [Abstract][Full Text] [Related]
11. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
Pittman DD; Millenson M; Marquette K; Bauer K; Kaufman RJ
Blood; 1992 Jan; 79(2):389-97. PubMed ID: 1730084
[TBL] [Abstract][Full Text] [Related]
12. Cleavage requirements for activation of factor V by factor Xa.
Thorelli E; Kaufman RJ; Dahlbäck B
Eur J Biochem; 1997 Jul; 247(1):12-20. PubMed ID: 9249003
[TBL] [Abstract][Full Text] [Related]
13. Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity.
Wiencek JR; Na M; Hirbawi J; Kalafatis M
J Biol Chem; 2013 Dec; 288(52):37026-38. PubMed ID: 24178294
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity.
Regan LM; Fay PJ
J Biol Chem; 1995 Apr; 270(15):8546-52. PubMed ID: 7721754
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-catalyzed activation of recombinant human factor V.
Keller FG; Ortel TL; Quinn-Allen MA; Kane WH
Biochemistry; 1995 Mar; 34(12):4118-24. PubMed ID: 7696276
[TBL] [Abstract][Full Text] [Related]
17. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
[TBL] [Abstract][Full Text] [Related]
18. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.
Ortel TL; Devore-Carter D; Quinn-Allen M; Kane WH
J Biol Chem; 1992 Feb; 267(6):4189-98. PubMed ID: 1740460
[TBL] [Abstract][Full Text] [Related]
19. Acidic Region Residues 1680-1684 in the A3 Domain of Factor VIII Contain a Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg1689.
Nakajima Y; Minami H; Nogami K
Thromb Haemost; 2021 Oct; 121(10):1274-1288. PubMed ID: 33592631
[TBL] [Abstract][Full Text] [Related]
20. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII.
Donath MS; Lenting PJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Feb; 270(8):3648-55. PubMed ID: 7876103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
